|
IGF2BP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.94030405262924E-11 |
| Normal-vs-Stage2 |
9.161800E-03 |
| Normal-vs-Stage3 |
4.278900E-03 |
| Normal-vs-Stage4 |
6.875800E-02 |
| Stage1-vs-Stage2 |
9.331800E-01 |
| Stage1-vs-Stage3 |
5.939400E-01 |
| Stage1-vs-Stage4 |
8.363600E-01 |
| Stage2-vs-Stage3 |
7.298600E-01 |
| Stage2-vs-Stage4 |
9.102200E-01 |
| Stage3-vs-Stage4 |
8.682600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.170050E-04 |
| Normal-vs-Asian |
4.950800E-01 |
| Caucasian-vs-AfricanAmerican |
2.536200E-02 |
| Caucasian-vs-Asian |
1.989560E-01 |
| AfricanAmerican-vs-Asian |
4.290000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.70079999994854E-06 |
| Male-vs-Female |
5.001000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.436600E-03 |
| Normal-vs-Extreme_Weight |
4.62689997426935E-09 |
| Normal-vs-Obese |
3.20129999953345E-07 |
| Normal-vs-Extreme_Obese |
1.368830E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.535160E-01 |
| Normal_Weight-vs-Obese |
1.091750E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.236000E-01 |
| Extreme_Weight-vs-Obese |
6.676800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.636000E-01 |
| Obese-vs-Extreme_Obese |
4.769200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.36819999999138E-05 |
| Normal-vs-Age(41-60Yrs) |
3.88256093941663E-12 |
| Normal-vs-Age(61-80Yrs) |
3.36429994973741E-09 |
| Normal-vs-Age(81-100Yrs) |
3.194200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.743380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.094290E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.504900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.428300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.619700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.484800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.801600E-01 |
| Normal-VS-KIRP CIMP |
3.46470000001098E-06 |
| Normal-VS-Unclassified PRCC |
2.119900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.60680002636582E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.55191999999804E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.332010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.77690084868232E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
1.760200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.17880000000271E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.054080E-02 |
| Normal-vs-N1 |
8.370000E-04 |
| Normal-vs-N2 |
8.727600E-02 |
| N0-vs-N1 |
3.060300E-02 |
| N0-vs-N2 |
2.369700E-02 |
| N1-vs-N2 |
3.522600E-01 |
|
|
